Sato Pharmaceutical Co., Ltd.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Orum, Vertex Ink Novel Protein-Deg

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus

Verrica Pharmaceuticals Inc. 's success in two Phase III studies – CAMP-1 and CAMP-2 – of its cantharidin formulation VP-102 for the skin disease molluscum puts the product on track for a US FDA filin

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer